arrow
B

Barnaby Edward Young

national centre for infectious diseases singapore
H指数:56
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Urinary suPAR and NGAL as biomarkers of disease severity in hospitalized adults with community-acquired pneumonia

尿suPAR和NGAL作为社区获得性肺炎住院成人疾病严重程度的生物标志物

2026-08-010
PRE
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants

NVX-CoV2372、单价mRNA和双价mRNA疫苗可诱导针对新兴SARS-CoV-2变种的中和抗体

2026-05-050
OA
Human indels as predictors of antibody responses to COVID-19 vaccines

人类插入缺失作为预测COVID-19疫苗抗体反应的指标

2025-09-010
OAAI
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination

突破性感染后与COVID-19 mRNA疫苗接种相关的癌症类型和基因特征

2025-05-090
OA
Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adults

早期中性粒细胞反应是预测成人重症COVID-19的潜在生物标志物。

2025-03-200
PRE
Defining the Critical Requisites for Accurate Simulation of SARS-CoV-2 Viral Dynamics: Patient Characteristics and Data Collection Protocol

定义准确模拟SARS-CoV-2病毒动力学所需的关键要素:患者特征与数据收集方案

2025-01-161
OAAI
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019
2024-09-120
PRE
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: fi nal results from the fi rst phase of the PRIBIVAC randomised clinical trial
2024-09-010
OAAI
Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research and outcome study (RESPIRO)
2024-01-230
OAAI
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity
2024-01-182
OAAI